Literature DB >> 15492998

ALK-positive diffuse large B-cell lymphoma of the stomach associated with a clathrin-ALK rearrangement.

D T McManus1, M A Catherwood, P D Carey, R J G Cuthbert, H D Alexander.   

Abstract

ALK-positive diffuse large B-cell lymphoma is a rare, recently characterized lymphoma subtype that shows granular cytoplasmic ALK expression. This report describes a primary gastric ALK-positive B-lineage lymphoma in which a clathrin (CLTC)-ALK fusion was identified by RT-PCR and direct sequencing of the breakpoint. This confirmed the presence of t(2;17)(p23;q23) involving the CLTC gene and is only the 4th report of such a translocation in this lymphoma subtype and the first to describe this tumor within the stomach. As in previous reports, immunophenotyping showed the malignant cell to be a terminally differentiated B-lineage cell characterized by the absence of B-cell antigens and expression of antigens associated with plasma cell differentiation. This case confirms the existence of such a lymphoma subtype arising in extranodal locations and underscores the importance of detailed immunophenotyping and specialized molecular genetic investigations in confirming the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15492998     DOI: 10.1016/j.humpath.2004.06.001

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  9 in total

1.  Clathrin heavy chain gene fusions expressed in human cancers: analysis of cellular functions.

Authors:  Maria K E Blixt; Stephen J Royle
Journal:  Traffic       Date:  2011-03-24       Impact factor: 6.215

Review 2.  Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma presenting in nasal cavity: a case report and review of literature.

Authors:  Ji Chen; Xiaoli Feng; Mei Dong
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 3.  Diffuse large B-cell lymphomas with plasmablastic differentiation.

Authors:  Julie Teruya-Feldstein
Journal:  Curr Oncol Rep       Date:  2005-09       Impact factor: 5.075

4.  Anaplastic lymphoma kinase-positive large B-cell lymphoma: a distinct clinicopathological entity.

Authors:  Shiyong Li
Journal:  Int J Clin Exp Pathol       Date:  2009-03-13

5.  Gastrointestinal lymphomas: Morphology, immunophenotype and molecular features.

Authors:  Marnelli A Bautista-Quach; Christopher D Ake; Mingyi Chen; Jun Wang
Journal:  J Gastrointest Oncol       Date:  2012-09

Review 6.  Small molecules in targeted cancer therapy: advances, challenges, and future perspectives.

Authors:  Lei Zhong; Yueshan Li; Liang Xiong; Wenjing Wang; Ming Wu; Ting Yuan; Wei Yang; Chenyu Tian; Zhuang Miao; Tianqi Wang; Shengyong Yang
Journal:  Signal Transduct Target Ther       Date:  2021-05-31

Review 7.  ALK: a tyrosine kinase target for cancer therapy.

Authors:  Vijaykumar R Holla; Yasir Y Elamin; Ann Marie Bailey; Amber M Johnson; Beate C Litzenburger; Yekaterina B Khotskaya; Nora S Sanchez; Jia Zeng; Md Abu Shufean; Kenna R Shaw; John Mendelsohn; Gordon B Mills; Funda Meric-Bernstam; George R Simon
Journal:  Cold Spring Harb Mol Case Stud       Date:  2017-01

Review 8.  ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature.

Authors:  Brady Beltran; Jorge Castillo; Renzo Salas; Pilar Quiñones; Domingo Morales; Fernando Hurtado; Luis Riva; Eric Winer
Journal:  J Hematol Oncol       Date:  2009-02-27       Impact factor: 17.388

9.  ALK-positive diffuse large B-cell lymphoma of the duodenum: A case report and review of the literature.

Authors:  Xiaoming Xing; Dongliang Lin; Wenwen Ran; Huamin Liu
Journal:  Exp Ther Med       Date:  2014-06-16       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.